The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 20, 2024
Filed:
Dec. 13, 2018
Applicant:
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Inventors:
Jian Yan, Wallingford, PA (US);
Anna Slager, Lansdale, PA (US);
Bradley Garman, Glenside, PA (US);
Neil Cooch, Oreland, PA (US);
Assignee:
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 31/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61P 35/00 (2006.01); C07K 16/40 (2006.01); C12N 15/52 (2006.01); C12N 15/62 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00115 (2018.08); A61K 39/39 (2013.01); A61P 35/00 (2018.01); C07K 16/40 (2013.01); C12N 15/52 (2013.01); C12N 15/62 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55527 (2013.01); A61K 2039/575 (2013.01);
Abstract
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens are disclosed. Methods of treating a subject with a Survivin-expressing tumor and methods of preventing a Survivin-expressing tumor are disclosed. Synthetic consensus Survivin antigens are disclosed.